A team of Canadian researchers at McMaster University is developing an inhalable TB vaccine that would act as a booster to strengthen immune protection right at the site of infection — the lungs. If successful, it would be among the first new effective TB vaccines in the world.
Organizations: | |
People: | |
Topics: |